PSQH Editor John Palmer recently interviewed Stacy Pur, Vice President of Product Development at VigiLanz, for a Q&A on clinical surveillance, patient safety, and COVID-19. Here’s an excerpt:
With a potential second wave of COVID-19 on the horizon for the fall, combined with the regular flu season, real-time surveillance alerts may be the key to infection prevention as well as mitigating and controlling future on-premises infections.
PSQH: If clinical surveillance is so important, why do only 29% of surveyed hospitals use it? What would improve the rate of surveillance usage?
You can read Stacy’s response, and more of the Q&A, on PSQH and HealthLeaders.
